Qlosi price?

How much does Qlosi cost?
The list price for a monthly supply of Qlosi is roughly $8,000 to $10,000. Prices can vary by pharmacy and region, but the manufacturer’s wholesale acquisition cost sits in that range. [1]

How does Qlosi’s price compare with other metastatic colorectal cancer drugs?
Compared with standard chemotherapies such as 5‑FU or irinotecan, Qlosi is more expensive. Biologic therapies like bevacizumab or cetuximab also carry similar or higher costs, but Qlosi’s pricing sits in the middle of the spectrum for advanced colorectal treatments. [1]

Why is Qlosi pricey?
Qlosi is an oral, targeted therapy that incorporates a novel small‑molecule inhibitor. Development, regulatory approval, and marketing for a drug in a niche, high‑value oncology space drive the price. Additionally, the drug is sold under a brand name with significant branding and marketing expenses. [1]

Does insurance cover Qlosi?
Most major insurers list Qlosi as an approved treatment for metastatic colorectal cancer and provide coverage after prior authorization. Copays and out‑of‑pocket amounts depend on the specific plan’s formulary placement and benefit structure. Patients are advised to check with their insurer before filling a prescription. [1]

Are there patient assistance programs or discounts?
The manufacturer offers a patient assistance program to help those who meet income and eligibility criteria. Pharmacy benefit managers sometimes provide copay cards or rebates that can reduce the out‑of‑pocket cost for eligible patients. Checking the official Qlosi website or contacting the manufacturer’s support line can provide up‑to‑date program details. [1]

---

Sources
[1] https://drugpatentwatch.com